| Jeffrey Robert Bender, PHARMD | |
|
155 W College Dr, Concordia, KS 66901-5207 | |
| (785) 243-1234 | |
| Not Available |
| Full Name | Jeffrey Robert Bender |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 155 W College Dr, Concordia, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326826579 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-100101 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Robert Bender, PHARMD 155 W College Dr, Concordia, KS 66901-5207 Ph: (785) 243-1234 | Jeffrey Robert Bender, PHARMD 155 W College Dr, Concordia, KS 66901-5207 Ph: (785) 243-1234 |
News Archive
COVID-19 Reflections: Severe lockdowns and Stay-at-Home orders have been hallmark of the national and global response to this Pandemic. They have been imposed with little precedent and scant evidence of their effectiveness as opposed to less restrictive social distancing measures.
A new classification of coronary congenital diseases is set to help surgeons identify secondary defects in the operating theatre. The scheme is outlined in a novel European Society of Cardiology position paper published today in Cardiovascular Research.1 Clinical cardiologists will also know what to look for on cardiovascular images.
Rigel Pharmaceuticals, Inc. and Bristol-Myers Squibb Company today announced that they have entered into a collaboration agreement for the discovery, development and commercialization of cancer immunotherapies based on Rigel's extensive portfolio of small molecule TGF beta receptor kinase inhibitors.
A new study by researchers at the University of Oxford and Harvard University and published on the preprint server medRxiv in July 2020 reports the use of artificial intelligence (AI) to screen patients presenting or admitted to hospital for COVID-19. This could help triage patients in low-testing settings and help reduce infection risk.
EU-funded researchers have taken the firsts steps towards future technologies combining silicon circuits and the nervous systems of mammals. Applications could include advanced drug screening and, perhaps one day, implants to help combat neurological disorders.
› Verified 3 days ago
Angela Steffen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 140 E College Dr, Concordia, KS 66901 Phone: 785-243-2805 Fax: 785-243-2524 | |
Carlee Baumann, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1526 Lincoln St, Concordia, KS 66901 Phone: 785-243-1212 | |
Anthony L Bombardier, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1020 Elmhurst Blvd, Concordia, KS 66901 Phone: 785-243-4414 Fax: 785-243-1827 | |
Kayla Hood, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1020 Elmhurst Blvd, Concordia, KS 66901 Phone: 785-243-4414 | |
Jason Branfort, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 140 E College Dr, Concordia, KS 66901 Phone: 785-243-2805 Fax: 785-243-2524 | |
Bryan Christopher Bombardier, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 124 W 6th St, Concordia, KS 66901 Phone: 785-614-3492 Fax: 785-340-3277 |